Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective effects of ginsenoside Rg2 against memory impairment and neuronal death induced by Aβ25-35 in rats
Jing Cui, Rui Shan, Yanqi Cao, et al.
Journal of Ethnopharmacology (2020) Vol. 266, pp. 113466-113466
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Hui‐Zhi Long, Yan Cheng, Ziwei Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 305
Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach
Seyede Nazanin Zarneshan, Sajad Fakhri, Haroon Khan
Pharmacological Research (2022) Vol. 177, pp. 106099-106099
Closed Access | Times Cited: 103
Ginsenoside Rg1 in neurological diseases: From bench to bedside
Shaojie Yang, Jing-ji Wang, Ping Cheng, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 913-930
Open Access | Times Cited: 55
Neuroprotective Potentials of Panax Ginseng Against Alzheimer’s Disease: A Review of Preclinical and Clinical Evidences
Jing Li, Qingxia Huang, Jinjin Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics
Jing Lu, Xian Wang, Anxin Wu, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 4, pp. 1523-1544
Closed Access | Times Cited: 31
Advancements in enzymatic biotransformation and bioactivities of rare ginsenosides：A Review
Hu Yanbo, Yiming Li, Yi Cao, et al.
Journal of Biotechnology (2024) Vol. 392, pp. 78-89
Closed Access | Times Cited: 7
Comparison between the Biological Active Compounds in Plants with Adaptogenic Properties (Rhaponticum carthamoides, Lepidium meyenii, Eleutherococcus senticosus and Panax ginseng)
Velislava Todorova, Kalin Ivanov, Stanislava Ivanova
Plants (2021) Vol. 11, Iss. 1, pp. 64-64
Open Access | Times Cited: 35
Ginsenoside and Its Therapeutic Potential for Cognitive Impairment
Hui Feng, Xue Mei, Hao Deng, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1310-1310
Open Access | Times Cited: 26
Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer’s disease by network pharmacology and molecular docking
Suet Cheung, Yuan Zhong, Lei Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117976-117976
Closed Access | Times Cited: 5
The role of PI3K signaling pathway in Alzheimer’s disease
Jingying Pan, Yao Qi, Yankai Wang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
In-Depth Investigation on Potential Mechanism of Forest-Grown Ginseng Alleviating Alzheimer’s Disease via UHPLC-MS-Based Metabolomics
Huazhou Niu, Meng Zhang, Kaiyue Zhang, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 93-93
Open Access
Ginseng and Polygonum multiflorum formula protects brain function in Alzheimer’s disease
Jingjing Liu, Feng Wei, Yadan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Molecular mechanisms of GDNF/GFRA1/RET and PI3K/AKT/ERK signaling interplay in neuroprotection: Therapeutic strategies for treating neurological disorders
Manzar Khan, Divya Choudhary, Sidharth Mehan, et al.
Neuropeptides (2025) Vol. 111, pp. 102516-102516
Closed Access
Identification of Adenylate Kinase 5 as a Protein Target of Ginsenosides in Brain Tissues Using Mass Spectrometry-Based Drug Affinity Responsive Target Stability (DARTS) and Cellular Thermal Shift Assay (CETSA) Techniques
Feiyan Chen, Li Chu, Huiying Cao, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 8, pp. 2741-2751
Closed Access | Times Cited: 19
Therapeutic Candidates for Alzheimer’s Disease: Saponins
Ruifeng Zhang, Miao Zeng, Xiaolu Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10505-10505
Open Access | Times Cited: 11
Ginsenoside Rg2 alleviates neurovascular damage in 3xTg-AD mice with Alzheimer's disease through the MAPK-ERK pathway
Xiaojun Ye, Sen Shao, Yanbo Wang, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 133, pp. 102346-102346
Open Access | Times Cited: 11
Ginsenosides Rg1 and Rg2 Activate Autophagy and Attenuate Oxidative Stress in Neuroblastoma Cells Overexpressing Aβ(1-42)
Ziqi Liu, Valentina Cecarini, Massimiliano Cuccioloni, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 310-310
Open Access | Times Cited: 4
Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer’s Disease
Qin Li, Limor Rubin, Marta Silva, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 16
Research Progress on Effects of Ginsenoside Rg2 and Rh1 on Nervous System and Related Mechanisms
Silu Liu, Weijia Chen, Yan Zhao, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7935-7935
Open Access | Times Cited: 9
Role of amyloid beta (25−35) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in Alzheimer's disease
Soudabeh Naderi, Fariba Khodagholi, Hamid Gholami Pourbadie, et al.
NeuroToxicology (2022) Vol. 94, pp. 71-86
Closed Access | Times Cited: 15
Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae
Chaojing Li, Xing Yan, Zhenzhen Xu, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Exploring the Potential Therapeutic Approach Using Ginsenosides for the Management of Neurodegenerative Disorders
Manju, Navneeta Bharadvaja
Molecular Biotechnology (2023) Vol. 66, Iss. 7, pp. 1520-1536
Closed Access | Times Cited: 8
Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats
Guang Liu, Jinli Zhang, Fangyi Sun, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 13
Advancements in research on the effects of panax notoginseng saponin constituents in ameliorating learning and memory disorders
Shusen Liu, Min Wang, Xiao Haiyan, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28581-e28581
Open Access | Times Cited: 2
Review on Ginseng and its Potential Active Substance G-Rg2 Against Age-Related Diseases: Traditional Efficacy and Mechanism
Yu-Zhuo Zhang, De-Yang Huo, Zhi Liu, et al.
Journal of Ethnopharmacology (2024), pp. 118781-118781
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top